Abstract:Background Whether the loss-of-function allele CYP3A5*3 variant is associated with significantly impaired metabolism of cyclosporine A (CsA) in transplant patients is still controversial because of the lack of prospective, large-scale clinical studies performed among diversely ethnic populations. Objectives This meta-analysis was designed to determine whether the CYP3A5*3 variant could affect CsA blood concentrations and the rate of acute rejection in renal transplant recipients. Methods and results All relevant publications were retrieved online from 1966 to March 2010, in which 14 studies were chosen, and 1821 renal transplant patients were enrolled. The results showed that there were significant differences in the CsA dose-adjusted trough concentration (C-0) between the CYP3A5*3/*3 and CYP3A5*1/*1 carriers [weighted mean difference (WMD): 10.06 mu g/l per mg/kg, 95% confidence interval (CI): 3.12-17.00, P = 0.004] and between the non-CYP3A5*1 allele carriers and the CYP3A5*1 allele carriers (WMD: 8.32 mu g/l per mg/kg, 95% CI: 3.16-13.49, P = 0.002). In addition, a subgroup analysis stratified by ethnicity indicated that a significant difference in CsA dose-adjusted C-0 was observed between the non-CYP3A5*1 allele carriers and the CYP3A5*1 allele carriers in Asian patients, but not in Caucasian patients. Moreover, a significant difference in the mean daily dose was observed between the non-CYP3A5*1 allele carriers and the CYP3A5*1 allele carriers (WMD: -0.19 mg/kg, 95% CI: -0.31 to -0.07, P = 0.002). However, the meta-analysis suggested that there was little or no association of the CYP3A5*3 variant with the acute rejection rate in renal transplant patients treated with CsA [odds ratio = 0.94, 95% CI: 0.57-1.54, P = 0.80]. Conclusion We concluded that the CYP3A5*3 variant could be associated, to a certain extent, with increased CsA dose-adjusted C-0 in blood and reduced mean daily doses, but that this genetic variant allele seemed to have little effect on the acute rejection rate in renal transplant patients taking CsA. Pharmacogenetics and Genomics 20: 525-531 (C) 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins.

Association of a CYP3A5 gene polymorphism with exacerbation in adult patients with asthma

Impact of CYP3A5 Polymorphisms on Pediatric Asthma Outcomes

Gene Polymorphisms of NLRP3 Associated With Plasma Levels of 4β‐Hydroxycholesterol, an Endogenous Marker of CYP3A Activity, in Patients With Asthma

[Methylenetetrahydrofolate Reductase [correction of Reducatase] Polymorphism and Asthma].

The primary ciliary dyskinesia-related genetic risk score is associated with susceptibility to adult-onset asthma

Methylenetetrahydrofolate reducatase polymorphism and asthma

Frequencies of Poor Metabolizers of Cytochrome P450 2C19 in Esophagus Cancer, Stomach Cancer, Lung Cancer and Bladder Cancer in Chinese Population

Association Between Tumor Necrosis Factor-Α Rs1800629 Polymorphism and Risk of Asthma: a Meta-Analysis.

17Q21 Locus Rs7216389 Polymorphism and Childhood Asthma Risk: a Meta-Analysis

Single‑nucleotide polymorphism rs6592645 confers asthma risk through regulating LRRC32 expression

Effects of the CYP3A5*3 variant on cyclosporine exposure and acute rejection rate in renal transplant patients: a meta-analysis.

Analysis of the GSTP1 rs1695 polymorphism association with the development of asthma and phenotypic manifestations

Association Between Polymorphisms/haplotypes of ADRB2 Gene and Asthma-Related Phenotypes in a South Chinese Han Population

Beta(2)-Adrenergic Receptor Haplotype/Polymorphisms And Asthma Susceptibility And Clinical Phenotype In A Chinese Han Population

Genetically High Angiotensin-Converting Enzyme Concentrations Causally Increase Asthma Risk: A Meta-Analysis Using Mendelian Randomization

Influence of CYP3A5 polymorphism on tacrolimus blood concentrations in renal transplant patients

Correlation between TNF- α -308 and +489 Gene Polymorphism and Acute Exacerbation of Chronic Obstructive Pulmonary Diseases

[Relationship between gene polymorphisms of tumor necrosis factor-α-308 and phenotypes of acute exacerbation of chronic obstructive pulmonary diseases]

CYP3A5*3 polymorphism and age affect tacrolimus blood trough concentration in myasthenia gravis patients

Optimization of bronchial asthma treatment according to polymorphism in the leukotriene-C4 synthase gene

T1 polymorphism in a disintegrin and metalloproteinase 33 (ADAM33) gene may contribute to the risk of childhood asthma in Asians